Related references
Note: Only part of the references are listed.Apramycin Overcomes the Inherent Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus
Petra Selchow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Translational in vitro and in vivo PKPD modelling for apramycin against Gram-negative lung pathogens to facilitate prediction of human efficacious dose in pneumonia
Vincent Aranzana-Climent et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice
Katja Becker et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Model-Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin
Tomas Sou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future
Craig R. Rayner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Antibacterial activity of apramycin at acidic pH warrants wide therapeutic window in the treatment of complicated urinary tract infections and acute pyelonephritis
Katja Becker et al.
EBIOMEDICINE (2021)
ENABLE: an engine for European antibacterial drug discovery and development
Marie Olliver et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Aminoglycosides in the Intensive Care Unit: What Is New in Population PK Modeling?
Alexandre Duong et al.
ANTIBIOTICS-BASEL (2021)
Dissemination of International Clone II Acinetobacter baumannii Strains Coproducing OXA-23 Carbapenemase and 16S rRNA Methylase ArmA in Athens, Greece
Konstantina Nafplioti et al.
MICROBIAL DRUG RESISTANCE (2020)
In vitro Activity of Apramycin Against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates
Mingju Hao et al.
FRONTIERS IN MICROBIOLOGY (2020)
Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae
Stefan Riedel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use
Masaaki Ishikawa et al.
SCIENTIFIC REPORTS (2019)
Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies
Michael Trang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii
Mario Juhas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates
Selina Y. L. Holbrook et al.
MICROBIAL DRUG RESISTANCE (2018)
Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model
Anthony D. Kang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates
Katherine A. Truelson et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies
Amelie Marsot et al.
CLINICAL PHARMACOKINETICS (2017)
Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy
C. C. Llanos-Paez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
In vitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
Anthony D. Kang et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Aminoglycosides: An Overview
Kevin M. Krause et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
In Vivo Efficacy of Apramycin in Murine Infection Models
Martin Meyer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose
R. J. Keizer et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin
Tanja Matt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development
D. R. Mould et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2012)
Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects
Robert T. Cass et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Antimicrobial therapy in critically ill patients - A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability
F Pea et al.
CLINICAL PHARMACOKINETICS (2005)
Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing
DW Xuan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Share Paper
